SCHD

Post by **admin** » Thu Jul 16, 2026 8:29 am

SCHDSummary

The Schwab U.S. Dividend Equity ETF has outperformed the S&P 500 year-to-date, silencing the detractors who thought it could never outshine.
SCHD offers less aggressive and volatile portfolio positioning with sector allocations favoring Healthcare (20.7%), Consumer Defensive (19%), and Energy (14%), plus +3.2% dividend yield.
Top SCHD holdings — Home Depot, Merck, UnitedHealth, Amgen — are A+ rated for profitability, supporting the ETF’s focus on dividend quality and stability.
I maintain a Buy rating on SCHD, citing its defensive characteristics, low beta (0.58), attractive valuation (14.3x P/E), and resilience amid market volatility.